How has Avalo Therapeutics's derivative liability, noncurrent changed year-over-year?

Avalo Therapeutics's derivative liability, noncurrent increased by 126.4% year-over-year, from $7.74M to $17.52M.

Avalo Therapeutics AVTX Derivative Liability, Noncurrent

Derivative Liability, Noncurrent at other companies

Chord EnergyCHRD

$10.2M+209%

TMC the metals company Inc.TMC

$912K—

New Jersey ResourcesNJR

$5.27M+50.0%

HighPeak Energy, Inc.HPK

$15.54M—

Black Stone MineralsBSM

$8.56M-57.8%

LivaNovaLIVN

$93.25M+151%

Other financials

Income statement

See full

Revenue$59.0K-69.3%

Gross profit$963.0K+8,855%

Operating income-$20.9M-42.5%

Net income-$19.6M-49.3%

EPS (diluted)-$0.98+21.6%

Balance sheet

See full

Cash & equivalents$25.3M-79.8%

Total debt$328.0K-59.1%

Total equity$68.3M-44.3%

Total assets$99.9M-27.9%

Cash flow

See full

Operating cash flow-$17.7M-87.1%

CapEx-—

Free cash flow-$15.0M-444%

Valuation

See full

Market cap$946.18M+1,783%

Enterprise value$921.19M-1,342%

P/S1,892.4×+1,852×

Profitability

See full

Gross margin182%+176pp

Operating margin-15,536.1%-17,275pp

Net margin-7,965.8%-10,750pp

FCF margin-11,123.8%-13,374pp

Returns & leverage

See full

Return on equity-88.8%—

Debt / equity0×0.0×

Current ratio7.7×-14.9×

Where this comes from

Reported directly by Avalo Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:DerivativeLiabilitiesNoncurrent.

The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avalo Therapeutics's derivative liability, noncurrent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Avalo Therapeutics's derivative liability, noncurrent?: Avalo Therapeutics (AVTX) reported derivative liability, noncurrent of $17.52M in Q1 2026.
How has Avalo Therapeutics's derivative liability, noncurrent changed year-over-year?: Avalo Therapeutics's derivative liability, noncurrent increased by 126.4% year-over-year, from $7.74M to $17.52M.